| Nome |
# |
|
Non-coding RNAs functioning in colorectal cancer stem cells, file e3ad891a-bb09-da0e-e053-3705fe0a2b96
|
1.690
|
|
Metastatic site location influences the diagnostic accuracy of ctDNA EGFR- mutation testing in NSCLC patients: a pooled analysis, file e3ad891c-7bb9-da0e-e053-3705fe0a2b96
|
954
|
|
Role of tumor-infiltrating lymphocytes in patients with solid tumors: Can a drop dig a stone?, file e3ad891d-4881-da0e-e053-3705fe0a2b96
|
548
|
|
Dietary restriction: could it be considered as speed bump on tumor progression road?, file e3ad8919-0b8f-da0e-e053-3705fe0a2b96
|
543
|
|
A headlight on liquid biopsies: a challenging tool for breast cancer management, file e3ad8919-1039-da0e-e053-3705fe0a2b96
|
392
|
|
Stabilizing versus destabilizing the microtubules: A double-edge sword for an effective cancer treatment option?, file e3ad8918-4793-da0e-e053-3705fe0a2b96
|
285
|
|
Nintedanib in NSCLC: Evidence to date and place in therapy, file e3ad8919-7361-da0e-e053-3705fe0a2b96
|
263
|
|
Can the microRNA expression profile help to identify novel targets for zoledronic acid in breast cancer?, file e3ad891a-6317-da0e-e053-3705fe0a2b96
|
250
|
|
E26The effects of LIPUS on ctDNA release in the medium of NSCLC cell lines, file e3ad891b-2783-da0e-e053-3705fe0a2b96
|
199
|
|
How to Deal with Second Line Dilemma in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis, file e3ad891f-ce1c-da0e-e053-3705fe0a2b96
|
196
|
|
Programmed Death Ligand 1 (PD-L1) as a Predictive Biomarker for Pembrolizumab Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC), file e3ad8921-474a-da0e-e053-3705fe0a2b96
|
160
|
|
BRCA1/2 pathogenic variants in triple-negative versus luminal-like breast cancers: genotype–phenotype correlation in a cohort of 531 patients, file e3ad8925-51cb-da0e-e053-3705fe0a2b96
|
159
|
|
Detection of RAS mutations in circulating tumor DNA: a new weapon in an old war against colorectal cancer. A systematic review of literature and meta-analysis, file e3ad8920-2855-da0e-e053-3705fe0a2b96
|
141
|
|
TTF-1/p63-positive poorly differentiated NSCLC: A histogenetic hypothesis from the basal reserve cell of the terminal respiratory unit, file e3ad8920-fe45-da0e-e053-3705fe0a2b96
|
139
|
|
Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2, file e3ad8922-ee6c-da0e-e053-3705fe0a2b96
|
136
|
|
LncRNA H19, HOTAIR AND MALAT1 AS MOLECULAR BIOMARKERS IN GIST, file e3ad891a-865c-da0e-e053-3705fe0a2b96
|
133
|
|
null, file e3ad891b-6cb8-da0e-e053-3705fe0a2b96
|
119
|
|
Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge, file e3ad8927-342f-da0e-e053-3705fe0a2b96
|
98
|
|
Moving the target on the optimal adjuvant strategy for resected pancreatic cancers: A systematic review with meta-analysis, file e3ad8921-9605-da0e-e053-3705fe0a2b96
|
95
|
|
Analysis of systemic inflammatory biomarkers in neuroendocrine carcinomas of the lung: prognostic and predictive significance of NLR, LDH, ALI, and LIPI score, file e3ad8922-e4c0-da0e-e053-3705fe0a2b96
|
95
|
|
Are Long Noncoding RNAs New Potential Biomarkers in Gastrointestinal Stromal Tumors (GISTs)? The Role of H19 and MALAT1, file e3ad8921-ef20-da0e-e053-3705fe0a2b96
|
91
|
|
Hereditary breast and ovarian cancer in families from southern Italy (Sicily)—Prevalence and geographic distribution of pathogenic variants in BRCA1/2 genes, file e3ad8922-de27-da0e-e053-3705fe0a2b96
|
91
|
|
Navigating the liquid biopsy Minimal Residual Disease (MRD) in non-small cell lung cancer: Making the invisible visible, file b7ea5aad-4f2d-45b8-a0e9-b5e45cdf82c1
|
80
|
|
The diagnostic accuracy of PIK3CA mutations by circulating tumor DNA in breast cancer: an individual patient data meta-analysis, file bde11d1e-a3c7-4772-a073-473b4c78c72c
|
76
|
|
The prognostic impact of tumor mutational burden (TMB) in the first-line management of advanced non-oncogene addicted non-small-cell lung cancer (NSCLC): a systematic review and meta-analysis of randomized controlled trials, file e3ad8927-4bd7-da0e-e053-3705fe0a2b96
|
70
|
|
Non-Small Cell Lung Cancer Harboring Concurrent EGFR Genomic Alterations: A Systematic Review and Critical Appraisal of the Double Dilemma, file e3ad8926-e916-da0e-e053-3705fe0a2b96
|
56
|
|
Extracellular Vesicles-ceRNAs as Ovarian Cancer Biomarkers: Looking into circRNA-miRNA-mRNA Code, file 51e99709-b887-4419-a62b-c54f4b38ddb3
|
51
|
|
CALR MUTATIONS IN SICILIAN ESSENTIAL THROMBOCYTHEMIA AND MYELOFIBROSIS PATIENTS., file e3ad891b-493b-da0e-e053-3705fe0a2b96
|
51
|
|
The role of microRNAs in driving EGFR-TKI resistance in NSCLC cell lines, file e3ad891b-68c8-da0e-e053-3705fe0a2b96
|
47
|
|
Not all KIT 557/558 codons mutations have the same prognostic influence on recurrence-free survival: breaking the exon 11 mutations in gastrointestinal stromal tumors (GISTs), file e3ad8927-33ba-da0e-e053-3705fe0a2b96
|
44
|
|
Is there any room for PD-1 inhibitors in combination with platinum-based chemotherapy as frontline treatment of extensive-stage small cell lung cancer? A systematic review and meta-analysis with indirect comparisons among subgroups and landmark survival analyses, file e3ad8927-5707-da0e-e053-3705fe0a2b96
|
42
|
|
Clinical Potential of Circulating Cell-Free DNA (cfDNA) for Longitudinally Monitoring Clinical Outcomes in the First-Line Setting of Non-Small-Cell Lung Cancer (NSCLC): A Real-World Prospective Study, file 1606f643-b66b-4e9f-96d7-5908f5d2d3de
|
38
|
|
Prognostic role of soluble PD-1 and BTN2A1 in overweight melanoma patients treated with nivolumab or pembrolizumab: finding the missing links in the symbiotic immune-metabolic interplay, file 1bd24d10-3d45-4e73-a4c4-698c69ce8bbb
|
33
|
|
Into the wild of long non-coding RNA in gastrointestinal stromal tumors (GISTs) to explore new prognostic/predictive biomarkers, file e3ad891a-81b7-da0e-e053-3705fe0a2b96
|
33
|
|
Exploring the Dynamic Crosstalk between the Immune System and Genetics in Gastrointestinal Stromal Tumors, file e1ff73b9-70c2-4089-bba2-b453fe3437b1
|
27
|
|
null, file e3ad891f-7c6c-da0e-e053-3705fe0a2b96
|
16
|
|
HEREDITARY BREAST AND OVARIAN CANCER SYNDROME: FREQUENCY AND DISTRIBUTION OF BRCA1/2 PATHOGENIC VARIANTS IN SICILIAN POPULATION, file e3ad8922-9b7e-da0e-e053-3705fe0a2b96
|
11
|
|
MOLECULAR ANALYSIS OF BRCA1/2 GENES AND MULTIGENE-PANEL TESTING IN SICILIAN TRIPLE NEGATIVE BREAST CANCER, file e3ad8921-5b72-da0e-e053-3705fe0a2b96
|
10
|
|
The prognostic role of KRAS and BRAF in patients undergoing surgical resection of colorectal cancer liver metastasis: a
systematic review and meta-analysis, file e3ad8920-1335-da0e-e053-3705fe0a2b96
|
9
|
|
KIT/PDGFRA Variant Allele Frequency as Prognostic Factor in Gastrointestinal Stromal Tumors (GISTs): Results From a Multi-Institutional Cohort Study, file 5bcfcd30-ad66-4a32-9917-8b67260bf7b8
|
7
|
|
Immuno-targeted combinations in oncogene-addicted non-small cell lung cancer, file e3ad891f-6c33-da0e-e053-3705fe0a2b96
|
6
|
|
Theranostic biomarkers and PARP-inhibitors effectiveness in patients with non-BRCA associated homologous recombination deficient tumors: Still looking through a dirty glass window?, file c0815438-99c9-4c20-bf69-b93a9a81826b
|
5
|
|
Liquid Biopsy in Gastrointestinal Stromal Tumor, file e3ad891c-6d78-da0e-e053-3705fe0a2b96
|
5
|
|
"Back to a false normality": New intriguing mechanisms of resistance to PARP inhibitors, file e3ad891a-bd84-da0e-e053-3705fe0a2b96
|
3
|
|
Role of tumor-infiltrating lymphocytes in patients with solid tumors: Can a drop dig a stone?, file e3ad8924-cf47-da0e-e053-3705fe0a2b96
|
2
|
|
Can the tumor-agnostic evaluation of MSI/MMR status be the common denominator for the immunotherapy treatment of patients with several solid tumors?, file e3ad8928-796d-da0e-e053-3705fe0a2b96
|
2
|
|
BRCA1/2 variants of unknown significance in hereditary breast and ovarian cancer (HBOC) syndrome: Looking for the hidden meaning, file e3ad8928-8d91-da0e-e053-3705fe0a2b96
|
2
|
|
Current clinically validated applications of liquid biopsy, file ee5a9af5-84ab-44b5-af90-0538b1429e6f
|
2
|
|
The significance of tissue-agnostic biomarkers in solid tumors: the more the merrier?, file f12e8bfc-bed4-4f77-a812-1b89d2cd27cb
|
2
|
|
Analysis of systemic inflammatory biomarkers in neuroendocrine carcinomas of the lung: prognostic and predictive significance of NLR, LDH, ALI, and LIPI score, file 07b51b46-370f-450c-904b-f15388f53f1e
|
1
|
|
Molecular tumor board, file 75aa294e-ca26-46c0-8da2-1f80ea1ef6e2
|
1
|
|
Potential miRNAs involved in molecular pathways mediating the anticancer effects of short term starvation in breast cancer cells treated with doxorubicin, file e3ad8921-f78a-da0e-e053-3705fe0a2b96
|
1
|
|
Impact of phospho-Akt expression on the clinical outcome and activity of gemcitabine and Akt inhibitors in pancreatic ductal adenocarcinoma, file e3ad8922-0df1-da0e-e053-3705fe0a2b96
|
1
|
|
Is there any place for PD-1/CTLA-4 inhibitors combination in the first-line treatment of advanced NSCLC?—A trial-level meta-analysis in PD-L1 selected subgroups, file e3ad8926-d001-da0e-e053-3705fe0a2b96
|
1
|
|
Cancer of the Thyroid, file e3ad8927-4776-da0e-e053-3705fe0a2b96
|
1
|
|
Future perspectives, file f42be372-2920-4d0f-9c63-c44ee24d3376
|
1
|
| Totale |
7.514 |